For the quarter ending 2026-03-31, ABT has $110,429M in assets. $6,803M in cash and cash equivalents.
| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 6,803 | 8,522 | 7,511 | 6,951 |
| Short-term investments | 492 | 417 | 222 | 331 |
| Trade receivables, less allowances of 494 in 2026 and 490 in 2025 | 8,210 | 7,929 | 8,138 | 7,972 |
| Finished products | 4,274 | 3,976 | 4,130 | 4,319 |
| Work in process | 994 | 904 | 961 | 962 |
| Materials | 1,721 | 1,608 | 1,617 | 1,673 |
| Total inventories | 6,989 | 6,488 | 6,708 | 6,954 |
| Prepaid expenses and other receivables | 3,014 | 2,640 | 2,260 | 2,260 |
| Total current assets | 25,508 | 25,996 | 24,839 | 24,468 |
| Investments | 1,090 | 918 | 951 | 958 |
| Land | - | 541 | - | - |
| Buildings | - | 4,543 | - | - |
| Equipment | - | 17,571 | - | - |
| Construction in progress | - | 2,567 | - | - |
| Property and equipment, at cost | 25,737 | 25,222 | 24,816 | 24,472 |
| Less accumulated depreciation and amortization | 13,360 | 13,406 | 13,312 | 13,077 |
| Net property and equipment | 12,377 | 11,816 | 11,504 | 11,395 |
| Intangible assets, net of amortization | 17,875 | 5,526 | 5,598 | 5,920 |
| Goodwill | 35,221 | 24,035 | 23,971 | 23,952 |
| Deferred income taxes and other assets | 18,358 | 18,422 | 17,318 | 17,306 |
| Total assets | 110,429 | 86,713 | 84,181 | 83,999 |
| Trade accounts payable | 4,679 | 4,240 | 4,123 | 4,306 |
| Salaries, wages, and commissions | 1,212 | 1,745 | 1,735 | 1,550 |
| Other accrued liabilities | 6,379 | 5,812 | 5,880 | 5,656 |
| Dividends payable | 1,100 | 1,097 | 1,030 | 1,030 |
| Income taxes payable | 598 | 569 | 469 | 390 |
| Current portion of long-term debt | 4,409 | 3,033 | 1,345 | 507 |
| Total current liabilities | 18,377 | 16,496 | 14,582 | 13,439 |
| Long-term debt | 29,638 | 9,896 | 11,596 | 12,930 |
| Defined benefit pension plans and post-employment medical and dental plans for significant plans | - | 2,125 | - | - |
| Net unrecognized tax benefits | - | 1,397 | - | - |
| Deferred income taxes | - | 559 | - | - |
| Operating lease liabilities | - | 931 | - | - |
| All other | - | 2,538 | - | - |
| Post-employment obligations, deferred income taxes, and other long-term liabilities | 9,713 | 7,550 | 6,739 | 6,801 |
| Preferred shares, one dollar par value authorized 1,000,000 shares, none issued | 0 | 0 | 0 | 0 |
| Common shares, without par value authorized 2,400,000,000 shares issued at stated capital amount shares 2026 1,998,233,756 2025 1,996,795,525 | 25,352 | 25,527 | 25,412 | 25,284 |
| Common shares held in treasury, at cost shares 2026 256,420,602 2025 260,196,074 | 16,935 | 17,177 | 16,877 | 16,610 |
| Earnings employed in the business | 49,956 | 49,781 | 49,103 | 48,467 |
| Accumulated other comprehensive income (loss) | -6,312 | -6,001 | -6,684 | -6,576 |
| Total abbott shareholders investment | 52,061 | 52,130 | 50,954 | 50,565 |
| Noncontrolling interests | 640 | 641 | 310 | 264 |
| Total shareholders investment | 52,701 | 52,771 | 51,264 | 50,829 |
| Total liabilities and shareholders' investment | 110,429 | 86,713 | 84,181 | 83,999 |
ABBOTT LABORATORIES (ABT)
ABBOTT LABORATORIES (ABT)